podophyllotoxin has been researched along with Cancer, Second Primary in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 23 (71.88) | 18.2507 |
| 2000's | 6 (18.75) | 29.6817 |
| 2010's | 2 (6.25) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, GT; Arnold, MA; Bhatia, S; Howell, RM; Hudson, MM; Im, C; Lu, Z; Neglia, JP; Ness, KK; Robison, LL; Sapkota, Y; Sharafeldin, N; Spector, LG; Turcotte, LM; Wang, Z; Yasui, Y; Yuan, Y | 1 |
| Allodji, RS; Benabdennebi, A; Chavaudra, J; Dayet, F; de Vathaire, F; Deutsch, E; Diallo, I; Diop, F; Haddy, N; Jackson, A; Labbé, M; Le Deley, MC; Lefkopoulos, D; Llanas, D; Oberlin, O; Rubino, C; Schwartz, B; Veres, C; Vu Bezin, J | 1 |
| Hijiya, N; Hudson, MM; Ness, KK; Ribeiro, RC | 1 |
| Debeljak, M; Dolžan, V; Erčulj, N; Faganel Kotnik, B; Jazbec, J | 1 |
| Aparicio Urtasun, J; Díaz Beveridge, R | 1 |
| Hanada, S; Otsuka, M; Owatari, S; Takeshita, T; Uozumi, K | 1 |
| Abramson, DH; Antoneli, CB; Bornfeld, N; Chantada, G; Dunkel, IJ; Gombos, DS; Greenwald, M; Haik, BG; Hungerford, J; Kingston, J; Leal, CA; Medina-Sanson, A; Schefler, AC; Veerakul, G; Wieland, R; Wilson, MW; Yu, CB | 1 |
| Apostolopoulou, E; Moschopoulos, N; Papakostas, P; Samelis, GF; Stathopoulos, GP | 1 |
| Evans, J; George, R; Pearson, AD; Reid, MM | 1 |
| Kumar, L | 1 |
| Rubinstein, L; Smith, MA; Ungerleider, RS | 1 |
| Ellis, M; Lishner, M; Ravid, M | 1 |
| Bowman, WP; Croce, CM; Felix, CA; Lange, BJ; Negrini, M; Winick, NJ | 1 |
| Crist, WM; Pui, CH; Rivera, GK | 1 |
| Behm, FG; Bowman, LC; Head, DR; Heaton, D; Hurwitz, CA; Pui, CH; Raimondi, SC; Sandoval, C | 1 |
| Murphy, SB | 1 |
| Cazenave, L; Gehan, E; Heyn, R; Khan, FM; Maurer, HM; Rubinstein, L; Smith, MA; Ungerleider, RS | 1 |
| Fukuda, H; Hyouchi, N; Ishiwata, D; Kamai, T; Masuda, H; Okuno, T; Tachibana, Y; Touma, T; Yonese, J | 1 |
| Anttila, VJ; Isomäki, HA; Kauppi, M; Savolainen, HA | 1 |
| Bowman, WP; Buchanan, GR; Friedman, DJ; Mustafa, MM; Sandler, ES; Winick, NJ | 1 |
| Karp, JE; Smith, MA | 1 |
| Geisler, C; Myhre, J; Pedersen, M; Pedersen-Bjergaard, J | 1 |
| Felix, CA | 1 |
| Blair, IA; Cheung, NK; Felix, CA; Lange, BJ; Lovett, BD; Nowell, PC; Rebbeck, TR; Walker, AH; Williams, TM; Winick, NJ | 1 |
| Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D | 1 |
| Amylon, MD; Bash, RO; Behm, FG; Camitta, B; Chen, C; Felix, CA; Kamen, BA; Pui, CH; Raimondi, SC; Relling, MV; Shuster, JJ; Winick, NJ; Woo, MH | 1 |
| Evans, WE; Hancock, ML; Hudson, MM; Kun, LE; Leung, W; Pui, CH; Razzouk, B; Ribeiro, RC; Rubnitz, JE; Sandlund, JT; Zhou, Y; Zhu, Y | 1 |
| Ratain, MJ; Rowley, JD | 1 |
| Kobayashi, K; Ratain, MJ | 1 |
| Chessells, JM; Hawkins, MM; Kingston, JE; Marsden, HB; Potok, MH; Stovall, MA; Wilson, LM | 1 |
| Hawkins, MM | 1 |
| Behm, FG; Evans, WE; Hancock, ML; Head, DR; Mahmoud, MH; Pui, CH; Raimondi, SC; Ribeiro, RC; Rivera, GK; Sandlund, JT | 1 |
9 review(s) available for podophyllotoxin and Cancer, Second Primary
| Article | Year |
|---|---|
Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.
Topics: Adolescent; Adult; Child; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 2009 |
[Therapy-related acute leukaemia and myelodysplastic syndrome].
Topics: Acute Disease; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Bone Marrow Transplantation; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Myelodysplastic Syndromes; Neoplasms; Neoplasms, Second Primary; Palliative Care; Podophyllotoxin; Prognosis | 2003 |
Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?
Topics: Antineoplastic Agents, Phytogenic; Child, Preschool; Cohort Studies; Databases, Factual; Enzyme Inhibitors; Female; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Podophyllotoxin; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Time Factors; Topoisomerase II Inhibitors | 2007 |
Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
Topics: Alkylating Agents; Cell Cycle; Child; Chromosomes, Human, Pair 11; Clinical Trials as Topic; Drug Administration Schedule; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Lymphoma, Non-Hodgkin; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Risk Factors; Topoisomerase II Inhibitors; Translocation, Genetic | 1994 |
A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias.
Topics: Alkylating Agents; DNA Damage; Humans; Leukemia; Neoplasms, Second Primary; Podophyllotoxin | 1993 |
[A case of secondary leukemia in anaplastic seminoma patient treated with long-term chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Podophyllotoxin; Seminoma; Testicular Neoplasms | 1996 |
The molecular pathogenesis of treatment-induced (secondary) leukemias: foundations for treatment and prevention.
Topics: Acute Disease; Antineoplastic Agents, Alkylating; DNA Damage; DNA Repair; Humans; Leukemia, Myeloid; Molecular Epidemiology; Neoplasms, Second Primary; Podophyllotoxin | 1997 |
Secondary leukemias induced by topoisomerase-targeted drugs.
Topics: Antineoplastic Agents, Alkylating; Chromosome Breakage; DNA Damage; DNA-Binding Proteins; Genes, Neoplasm; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Podophyllotoxin; Proto-Oncogenes; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic | 1998 |
Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes.
Topics: Acute Disease; Antineoplastic Agents; DNA Damage; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Topoisomerase II Inhibitors | 1992 |
2 trial(s) available for podophyllotoxin and Cancer, Second Primary
| Article | Year |
|---|---|
High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Risk Factors | 1997 |
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Risk Factors; Teniposide | 1991 |
21 other study(ies) available for podophyllotoxin and Cancer, Second Primary
| Article | Year |
|---|---|
Polygenic Risk and Chemotherapy-Related Subsequent Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study and St Jude Lifetime Cohort Study Report.
Topics: Adult; Breast Neoplasms; Cancer Survivors; Child; Cohort Studies; Female; Humans; Neoplasms, Second Primary; Podophyllotoxin; Risk Factors | 2023 |
Risk of Subsequent Leukemia After a Solid Tumor in Childhood: Impact of Bone Marrow Radiation Therapy and Chemotherapy.
Topics: Adolescent; Analysis of Variance; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bone Marrow; Case-Control Studies; Child; Child, Preschool; Confidence Intervals; Female; Humans; Infant; Leukemia; Leukemia, Radiation-Induced; Male; Neoplasms; Neoplasms, Second Primary; Odds Ratio; Platinum Compounds; Podophyllotoxin; Radiation Dosage | 2015 |
DNA repair polymorphisms influence the risk of second neoplasm after treatment of childhood acute lymphoblastic leukemia.
Topics: Adolescent; Alleles; Anthracyclines; Antineoplastic Agents; Case-Control Studies; Cell Cycle Proteins; Child; Child, Preschool; DNA Repair; DNA-Binding Proteins; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Infant; Male; Neoplasms, Second Primary; Nuclear Proteins; Podophyllotoxin; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy; Risk Factors; Survival Analysis | 2012 |
Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphoma.
Topics: Acute Disease; Alkylating Agents; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Podophyllotoxin | 2007 |
Acute non-lymphocytic leukaemia complicating gastric cancer treated with epipodophyllotoxin containing chemotherapy and G-CSF.
Topics: Antineoplastic Combined Chemotherapy Protocols; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Podophyllotoxin; Stomach Neoplasms | 1994 |
Secondary chronic myelomonocytic leukemia with t(9;11) in a child.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Female; Humans; Leukemia, Myelomonocytic, Chronic; Lymphoma, T-Cell; Neoplasms, Second Primary; Podophyllotoxin; Translocation, Genetic | 1994 |
Epipodophyllotoxins and secondary leukaemia.
Topics: Etoposide; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary; Podophyllotoxin | 1993 |
Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.
Topics: Child, Preschool; Chromosomes, Human, Pair 11; DNA-Cytosine Methylases; DNA, Neoplasm; Etoposide; Humans; Leukemia, Monocytic, Acute; Male; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic | 1993 |
The epipodophyllotoxins: both sides of the coin.
Topics: Acute Disease; Child; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1993 |
Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.
Topics: Acute Disease; Adolescent; Alkylating Agents; Antineoplastic Agents; Child; Combined Modality Therapy; Dactinomycin; Doxorubicin; Female; Humans; Intercalating Agents; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Podophyllotoxin; Radiotherapy; Topoisomerase II Inhibitors; Translocation, Genetic | 1993 |
Secondary acute myeloid leukemia following treatment with epipodophyllotoxins.
Topics: Acute Disease; Child; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Failure | 1993 |
Report of the Cancer Therapy Evaluation Program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins.
Topics: Acute Disease; Adult; Child; Clinical Trials as Topic; Etoposide; Humans; Incidence; Leukemia, Myeloid; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin | 1993 |
Leukaemia during podophyllotoxin treatment in a patient with juvenile chronic arthritis.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Glycosides; Humans; Leukemia; Lignans; Neoplasms, Second Primary; Podophyllotoxin | 1996 |
Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia.
Topics: Acute Disease; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Podophyllotoxin; Survival Analysis | 1997 |
Association of CYP3A4 genotype with treatment-related leukemia.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Chromosome Mapping; Chromosomes, Human, Pair 11; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA-Binding Proteins; Ethnicity; Female; Histone-Lysine N-Methyltransferase; Humans; Karyotyping; Leukemia; Male; Mixed Function Oxygenases; Myeloid-Lymphoid Leukemia Protein; Neoplasms; Neoplasms, Second Primary; Phenotype; Podophyllotoxin; Proto-Oncogenes; Racial Groups; Transcription Factors; United States | 1998 |
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Infant; Leukemia, Myeloid; Life Tables; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Prednisolone; Prednisone; Procarbazine; Retrospective Studies; Risk; Salvage Therapy; Vinblastine; Vincristine | 1999 |
Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies.
Topics: Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Genotype; Glutathione Transferase; Humans; Leukemia, Myeloid, Acute; Male; Mixed Function Oxygenases; Neoplasms, Second Primary; Podophyllotoxin; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; United States | 2000 |
Second malignancy after treatment of childhood non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Neoplasms, Second Primary; Podophyllotoxin; Retrospective Studies; Risk Factors; Survivors | 2001 |
New perspectives on the toxicity of etoposide.
Topics: Bone Marrow Diseases; Etoposide; Humans; Leukemia; Neoplasms, Second Primary; Podophyllotoxin | 1992 |
Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer.
Topics: Alkylating Agents; Antineoplastic Agents; Bone Marrow; Case-Control Studies; Child; Cohort Studies; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Humans; Leukemia; Neoplasms, Second Primary; Podophyllotoxin; Radiotherapy; Risk Factors | 1992 |
Secondary leukaemia after epipodophyllotoxins.
Topics: Case-Control Studies; Child; Humans; Leukemia; Neoplasms, Second Primary; Podophyllotoxin | 1991 |